Patents Assigned to CHONGQING PHARMACEUTICAL INDUSTRIAL RESEARCH INSTITUTE CO., LTD
  • APPLICATION OF COMBINATION OF QUINOLINE DERIVATIVE AND IMMUNOMODULATOR IN PREPARATION OF ANTITUMOR DRUGS
    Publication number: 20220175756
    Abstract: Provided is an application of the combination of a quinoline derivative and an immunomodulator in preparation of antitumor drugs.
    Type: Application
    Filed: March 16, 2020
    Publication date: June 9, 2022
    Applicants: CHONGQING PHARMACEUTICAL INDUSTRIAL RESEARCH INSTITUTE CO., LTD., YAOPHARMA CO., LTD.
    Inventors: Yang ZHANG, Zhengxia CHEN, Jian LI, Shuhui CHEN
  • Quinoline derivative and use thereof as tyrosine kinase inhibitor
    Patent number: 11161817
    Abstract: A quinoline derivative compound shown in formula (II), a pharmaceutically acceptable salt thereof, and an application of the same in preparing a drug for treating a disease related to a tyrosine kinase inhibitor.
    Type: Grant
    Filed: September 20, 2018
    Date of Patent: November 2, 2021
    Assignees: CHONGQING PHARMACEUTICAL INDUSTRIAL RESEARCH INSTITUTE CO. LTD., YAOPHARMA CO., LTD.
    Inventors: Yang Zhang, Zhengxia Chen, Meibi Dai, Wenju Li, Jian Li, Shuhui Chen
  • CRYSTAL FORM I OF CANAGLIFLOZIN AND PREPARATION METHOD THEREOF
    Publication number: 20170342061
    Abstract: Disclosed in the present invention is a crystal form I of Canagliflozin, and an X-ray powder diffraction spectrum of the crystal form I has characteristic diffraction peaks when 2? is at the position of 4.4±0.2°, 8.4±0.2°, 16.8±0.2°, 17.5±0.2°, 18.0±0.2°, and 22.8±0.2°. The crystal form is physically and chemically stable and is suitable for manufacturing of various preparations.
    Type: Application
    Filed: March 27, 2015
    Publication date: November 30, 2017
    Applicant: CHONGQING PHARMACEUTICAL INDUSTRIAL RESEARCH INSTITUTE CO., LTD
    Inventors: Fei WANG, Jian ZHANG, Meng LIN, Yuanfu TANG, Hao CHEN, Huangshu LEI